|
Volumn 61, Issue 3, 2002, Pages
|
Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
ANTIPARKINSON AGENT;
CARBIDOPA;
LEVODOPA;
AGED;
ARTICLE;
CASE REPORT;
CHEMICALLY INDUCED DISORDER;
CHRONIC MYELOID LEUKEMIA;
HUMAN;
MALE;
PARKINSON DISEASE;
TREATMENT OUTCOME;
AGED;
ANTINEOPLASTIC AGENTS;
ANTIPARKINSON AGENTS;
CARBIDOPA;
HUMANS;
INTERFERON ALFA-2B;
LEUKEMIA, MYELOID, CHRONIC;
LEVODOPA;
MALE;
PARKINSON DISEASE, SECONDARY;
TREATMENT OUTCOME;
|
EID: 0036519298
PISSN: 00178594
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (0)
|